The claims this storefront makes
We could not read this storefront. Eternal Peptides’ site at eternalpeptides.com returned HTTP 503 with a Retry-After header of 86400 seconds when we fetched it on October 19, 2026, which means the server told us to come back in a day. Because of that, every on-site field in this report is unverified: the catalog, the certificate program, pricing, shipping terms, payment methods, the returns policy, the research-use disclaimer and the contact details all come from secondary sources named below rather than from the supplier’s own pages. A reader should weigh what follows accordingly. We do not hold an outage against a company, but we also cannot credit claims we could not see.
With the site down, the claims we can list are the ones secondary sources attribute to it. Peptide Protocol Wiki reports third-party certificates from Janoshik Analytical on product pages, viewable without an account; about 23 products including BPC-157, Epitalon, GHK-Cu, Ipamorelin, MOTS-C, PT-141, Sermorelin and TB-500 plus GLP-class products; and US-only USPS Priority Mail shipping in two to four business days, free over $200, card only. Finnrick, an independent testing aggregator, reports that the brand has claimed on social media to be “number one” on Finnrick. No certification is claimed in our record, and no returns policy or guarantee is recorded.
We read the wiki page, both Finnrick vendor pages and the Trustpilot profile, and we searched FDA correspondence for the brand and for the legal entity Finnrick identifies.
What held up when we checked
Very little can be confirmed against the primary source, because there is no primary source to confirm against. Two secondary items are worth stating plainly. First, the wiki’s description of public Janoshik Analytical certificates on product pages is a favorable claim if true, and we note it as reported; the laboratory name is excluded from our confirmed-labs field because we could not see it on the vendor’s own pages. Second, Finnrick’s identification of the legal entity, Cenvira LLC in New York, ZIP 11362, through terms of service, DBA and trademark filings, is the most concrete fact in the file. It gives the brand a real-world owner, which is more than several suppliers whose sites we could load have offered.
The wiki also describes the practical terms a buyer would meet if the site were up: about 23 products, US-only USPS Priority Mail shipping in two to four business days, free over $200, and card as the only payment method. We repeat those as the wiki’s description. None of them could be confirmed, and a reader who finds the site back online should check each against the live pages rather than against this report.
What did not, and what we could not verify
The “number one on Finnrick” social claim is contradicted by Finnrick’s own data, which places the vendor well down its table. A company that cites an aggregator’s standing should expect the aggregator’s numbers to be checked, and here they do not support the boast.
The Trustpilot profile has been removed with Trustpilot’s standard notice that it “goes against our guidelines.” Finnrick reports undisclosed promotional placements on Reddit and Quora, which means some of the positive coverage a searcher finds may have been paid for. Finnrick also reports that brand signals begin only in 2024, that the .com domain was captured for sale in July 2025 before becoming the store, that a lookalike domain, eternalpep.com, exists, and that an earlier lab-tests page exposed WordPress admin edit URLs. Payment methods, per Finnrick, moved from Zelle, CashApp and Bitcoin to card processing. All of that is Finnrick’s reporting, not ours, and we attribute it as such.
The independent testing record is the heart of this report. Finnrick reports 28 tests of this vendor’s products: 10 passes and 18 fails. BPC-157, the item most buyers compare across suppliers, is rated 37 percent over 10 tests, with the most recent result a fail on September 15, 2026. A July 2026 Finnrick report showed two GLP-class products at 0 of 4 each. Other items scored higher in Finnrick’s file, with one GLP-class product at 75 percent, another at 70 percent and Melanotan II at 70 percent. Read together, that is a supplier whose products fail an independent retest more often than they pass, with the failures concentrated in the product most people would order first.
Everything on the site itself is unverified. The support email, [email protected], comes from Finnrick and could not be confirmed. Whether a research-use disclaimer is present is unknown. The exact location is not disclosed on the site, according to the wiki. No FDA warning letter naming Eternal Peptides or Cenvira LLC appears in our record.
Our read
A site that will not load cannot be verified, and we say so rather than guess. What we can weigh is the independent record, and it is poor. Eighteen failures in twenty-eight tests, a BPC-157 line that fails more than it passes with the latest fail a month before our check, a removed review profile, undisclosed promotion and a public boast that the aggregator’s own numbers contradict. The reported Janoshik certificates would be a point in the company’s favor if we could see them, but a certificate the vendor commissions does not outweigh a retest the vendor did not.
If the site comes back, we will read it and revise, starting with whether the Janoshik certificates the wiki describes are lot-specific and whether they cover the BPC-157 lots Finnrick failed. Until then, and until the Finnrick trend reverses, there is no case for ordering, and a research purchaser who finds Eternal Peptides recommended on a forum should ask whether that recommendation was one of the placements Finnrick describes.
